Stock listing

CERT Stock Price, News, Filings & Events — Certara, Inc.

Selected listing: CERT · NASDAQ · USD · US

This page tracks Certara, Inc.'s CERT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CERT:NASDAQ. CERT:NASDAQ is the stock-level entry point for investors researching Certara, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Certara, Inc. is a public company traded under the ticker CERT in the American market. With a market capitalization of approximately $1.17 billion, Certara specializes in providing software and services that enhance drug development and regulatory approval processes. The company focuses on advancing the use of modeling and simulation in the life sciences industry.

CERT:NASDAQUSDUSUpdated August 21, 2026
Certara, Inc. logo
Ticker
CERT:NASDAQ
Asset type
Stock
Market cap
$1.29B
Sector
Technology Services
Industry
Packaged Software
Exchange
NASDAQ
Currency
USD

Certara, Inc. CERT:NASDAQ stock context

This page tracks Certara, Inc.'s CERT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CERT:NASDAQ. CERT:NASDAQ is the stock-level entry point for investors researching Certara, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Certara, Inc. is a public company traded under the ticker CERT in the American market. With a market capitalization of approximately $1.17 billion, Certara specializes in providing software and services that enhance drug development and regulatory approval processes. The company focuses on advancing the use of modeling and simulation in the life sciences industry.

Latest news from Certara, Inc.

All Certara, Inc. news →

Certara, Inc. earnings calls

Research Certara, Inc.

Alternate listings